Danish drug maker Novo Nordisk will invest 70 million euros ($78 million) to build a manufacturing plant in Iran, joining...
Read moreTakeda Pharmaceutical Company Limited ("Takeda") (TSE: 4502) announced today that it has submitted a New Drug Application ("NDA") to the...
Read moreTakeda Pharmaceutical Company Ltd. (“Takeda”, TSE: 4502) has been selected for the Dow Jones Sustainability Asia Pacific Index (DJSI Asia...
Read moreFor the seventh consecutive year, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as the Group Leader in sustainability...
Read moreToday announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts – a strategic location...
Read moreApplication includes CheckMate -066, a clinical trial of Opdivo vs. dacarbazine chemotherapy in patients who had not received prior therapy...
Read moreParticulate Systems, a brand of Micromeritics, has completed the full acquisition of Subsieve Autosizer from HEL. The agreement was finalised...
Read moreG-CON Manufacturing has been selected to build a multi-POD ISO Class 7 Formulation and Filling Suite for the University of...
Read moreNovartis presented new data that demonstrated once-daily Ultibro® Breezhaler® (indacaterol/glycopyrronium bromide) was superior in reducing exacerbations (flare ups) and improving...
Read moreLaw enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and the United Kingdom, supported by Europol and Eurojust,...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.